Business Description
Forte Biosciences Inc
NAICS : 541714
SIC : 2834
ISIN : US34962G1094
Share Class Description:
FRA:37TA: Ordinary SharesDescription
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.91 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 18.9 | |||||
| 3-Year EPS without NRI Growth Rate | 20.1 | |||||
| 3-Year FCF Growth Rate | 28.6 | |||||
| 3-Year Book Growth Rate | -40.4 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 55.83 | |||||
| 9-Day RSI | 53.27 | |||||
| 14-Day RSI | 52.72 | |||||
| 6-1 Month Momentum % | 53.38 | |||||
| 12-1 Month Momentum % | -32.09 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 10.45 | |||||
| Quick Ratio | 10.45 | |||||
| Cash Ratio | 10.13 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -41.5 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -91.3 | |||||
| ROA % | -79.99 | |||||
| ROIC % | -2542.74 | |||||
| ROC (Joel Greenblatt) % | -41121.52 | |||||
| ROCE % | -94.23 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.77 | |||||
| Price-to-Tangible-Book | 0.76 | |||||
| EV-to-EBIT | 0.31 | |||||
| EV-to-EBITDA | 0.31 | |||||
| EV-to-FCF | 0.35 | |||||
| Price-to-Net-Current-Asset-Value | 0.78 | |||||
| Price-to-Net-Cash | 0.81 | |||||
| Earnings Yield (Greenblatt) % | 322.58 | |||||
| FCF Yield % | -105.73 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Forte Biosciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.968 | ||
| Beta | 1.16 | ||
| Volatility % | 81.27 | ||
| 14-Day RSI | 52.72 | ||
| 14-Day ATR (€) | 0.018373 | ||
| 20-Day SMA (€) | 0.647 | ||
| 12-1 Month Momentum % | -32.09 | ||
| 52-Week Range (€) | 0.312 - 0.99 | ||
| Shares Outstanding (Mil) | 36.44 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Forte Biosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Forte Biosciences Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Forte Biosciences Inc Frequently Asked Questions
What is Forte Biosciences Inc(FRA:37TA)'s stock price today?
The current price of FRA:37TA is €0.65. The 52 week high of FRA:37TA is €0.99 and 52 week low is €0.31.
When is next earnings date of Forte Biosciences Inc(FRA:37TA)?
The next earnings date of Forte Biosciences Inc(FRA:37TA) is 2024-05-15 Est..
Does Forte Biosciences Inc(FRA:37TA) pay dividends? If so, how much?
Forte Biosciences Inc(FRA:37TA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers